
SRI 37892
CAS No. 1030769-75-5
SRI 37892( SRI37892 | SRI-37892 )
Catalog No. M10150 CAS No. 1030769-75-5
SRI 37892 (SRI37892) is a novel potent, small molecule Frizzled 7 (Fzd 7) inhibitor with IC50 of 0.66 uM in Wnt/β-catenin assay.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
![]() ![]() |
10MG | 1161 | Get Quote |
![]() ![]() |
25MG | 1755 | Get Quote |
![]() ![]() |
50MG | 2358 | Get Quote |
![]() ![]() |
100MG | 3177 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSRI 37892
-
NoteResearch use only, not for human use.
-
Brief DescriptionSRI 37892 (SRI37892) is a novel potent, small molecule Frizzled 7 (Fzd 7) inhibitor with IC50 of 0.66 uM in Wnt/β-catenin assay.
-
DescriptionSRI 37892 (SRI37892) is a novel potent, small molecule Frizzled 7 (Fzd 7) inhibitor with IC50 of 0.66 uM in Wnt/β-catenin assay; also displays potent activity against Wnt/β-catenin signaling in LRP6-expressing HEK293 cells with IC50 of 0.78 uM, demonstrates potent activity against breast cancer HS578T and BT549 cell proliferation with IC50 of 2.2 and 1.9 uM, respectively; targets Fzd7 transmembrane domain (TMD) and bolcks Wnt/Fzd7 signaling.
-
In Vitro——
-
In Vivo——
-
SynonymsSRI37892 | SRI-37892
-
PathwayWnt/Notch/Hedgehog
-
TargetFrizzled
-
RecptorFrizzled
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1030769-75-5
-
Formula Weight465.531
-
Molecular FormulaC26H19N5O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=NC(C2=CC3=C(NC(CC3)=O)C=C2)=CS1)C4=CC=C(N5C=NC6=CC=CC=C56)C=C4
-
Chemical Name4-(1H-benzo[d]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang W, et al. Oncotarget. 2017 Sep 6;8(53):91459-91470.
molnova catalog



related products
-
FzM1
A negative allosteric modulator of the Frizzled4 (Fzd4) receptor and a Wnt/β-catenin pathway inhibitor with pEC50 value of 5.74 for inhibition of Wnt antagonism.
-
NSC654259
A novel small molecule Wnt signaling inhibitor that targets the cysteine-rich domain of Frizzled.
-
Peptide Fz7-21
Peptide Fz7-21 is a potent, selective peptide inhibitor of Frizzled 7 receptor, inhibits exogenous WNT3A stimulated Wnt-β-catenin signaling in HEK293 cells with IC50 of 100 nM.